The association between education and risk of major cardiovascular events among prostate cancer patients: a study from the Diet, Cancer and Health study

References

• Marså K, Johnsen NF, Bidstrup PE, et al. Social inequality and incidence of and survival from male genital cancer in a population-based study in Denmark, 1994–2003. Eur J Cancer. 2008;44:2018–2029.
   PubMed Web of Science ®Google Scholar
• Klein J, Hofreuter-Gätgens K, Lüdecke D, et al. Socioeconomic status and health-related quality of life among patients with prostate cancer 6 months after radical prostatectomy: a longitudinal analysis. BMJ Open. 2016;6(6):e010968.
   Google Scholar
• Berglund A, Garmo H, Robinson D, et al. Differences according to socioeconomic status in the management and mortality in men with high risk prostate cancer. Eur J Cancer. 2012;48:75–84.
   PubMed Web of Science ®Google Scholar
• Larsen SB, Brasso K, Christensen J, et al. Socioeconomic position and mortality among patients with prostate cancer: influence of mediating factors. Acta Oncol. 2017;56:563–568.
   PubMed Web of Science ®Google Scholar
• Berglund A, Garmo H, Tishelman C, et al. Comorbidity, treatment and mortality: a population based cohort study of prostate cancer in PCBaSe Sweden. J Urol. 2011;185:833–840.
   PubMed Web of Science ®Google Scholar
• Jespersen CG, Nørgaard M, Bjerklund Johansen TE, et al. The influence of cardiovascular morbidity on the prognosis in prostate cancer. Experience from a 12-year nationwide Danish population-based cohort study. BMC Cancer. 2011;11:519.
   PubMed Web of Science ®Google Scholar
• Van Hemelrijck M, Folkvaljon Y, Adolfsson J, et al. Causes of death in men with localized prostate cancer: a nationwide, population-based study. BJU Int. 2016;117:507–514.
   PubMed Web of Science ®Google Scholar
• Riihimäki M, Thomsen H, Brandt A, et al. What do prostate cancer patients die of? Oncologist. 2011;16:175–181.
   PubMed Web of Science ®Google Scholar
• Zhao J, Zhu S, Sun L, et al. Androgen deprivation therapy for prostate cancer is associated with cardiovascular morbidity and mortality: a meta-analysis of population-based observational studies. PLoS ONE. 2014;9:e107516.
   PubMed Web of Science ®Google Scholar
• Bosco C, Bosnyak Z, Malmberg A, et al. Quantifying observational evidence for risk of fatal and nonfatal cardiovascular disease following androgen deprivation therapy for prostate cancer: a meta-analysis. Eur Urol. 2015;68:386–396.
   PubMed Web of Science ®Google Scholar
• O'Farrell S, Garmo H, Holmberg L, et al. Risk and timing of cardiovascular disease after androgen-deprivation therapy in men with prostate cancer. J Clin Oncol. 2015;33:1243–1251.
   PubMed Web of Science ®Google Scholar
• Moustsen IR, Larsen SB, Tjønneland A, et al. Lifestyle, anthropometry and cardiovascular risk factors does not explain increased risk of cardiovascular disease in prostate cancer patients. Eur Urol Suppl. 2018;17:e106.
   Google Scholar
• Christensen AV, Koch MB, Davidsen M, et al. Educational inequality in cardiovascular disease depends on diagnosis: a nationwide register based study from Denmark. Eur J Prev Cardiol. 2016;23:826–833.
   PubMed Web of Science ®Google Scholar
• Tjønneland A, Olsen A, Boll K, et al. Study design, exposure variables, and socioeconomic determinants of participation in Diet, Cancer and Health: a population-based prospective cohort study of 57,053 men and women in Denmark. Scand J Public Health. 2007;35:432–441.
   PubMed Web of Science ®Google Scholar
• Gjerstorff ML. The Danish Cancer Registry. Scand J Public Health. 2011;39:42–45.
   PubMed Web of Science ®Google Scholar
• Jensen VM, Rasmussen AW. Danish education registers. Scand J Public Health. 2011;39:91–94.
   PubMed Web of Science ®Google Scholar
• Baadsgaard M, Quitzau J. Danish registers on personal income and transfer payments. Scand J Public Health. 2011;39:103–105.
   PubMed Web of Science ®Google Scholar
• Lynge E, Sandegaard JL, Rebolj M. The Danish National Patient Register. Scand J Public Health. 2011;39:30–33.
   PubMed Web of Science ®Google Scholar
• Helweg-Larsen K. The Danish Register of causes of death. Scand J Public Health. 2011;39:26–29.
   PubMed Web of Science ®Google Scholar
• Thygesen SK, Christiansen CF, Christensen S, et al. The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients. BMC Med Res Methodol. 2011;11:83–88.
   PubMed Web of Science ®Google Scholar
• Krarup LH, Boysen G, Janjua H, et al. Validity of stroke diagnoses in a national register of patients. Neuroepidemiology. 2007;28:150–154.
   PubMed Web of Science ®Google Scholar
• Sundbøll J, Adelborg K, Munch T, et al. Positive predictive value of cardiovascular diagnoses in the Danish National Patient Registry: a validation study. BMJ Open. 2016;6:e012832.
   Web of Science ®Google Scholar
• Larsen SB, Dalton SO, Schüz J, et al. Mortality among participants and non-participants in a prospective cohort study. Eur J Epidemiol. 2012;27:837–845.
   PubMed Web of Science ®Google Scholar
• Guessous I, Cullati S, Fedewa SA, et al. Prostate cancer screening in Switzerland: 20-year trends and socioeconomic disparities. Prev Med. 2016;82:83–91.
   PubMed Web of Science ®Google Scholar
• Liu L, Cozen W, Bernstein L, et al. Changing relationship between socioeconomic status and prostate cancer incidence. J Natl Cancer Inst. 2001;93:705–709.
   PubMedGoogle Scholar
• Tomic K, Ventimiglia E, Robinson D, et al. Socioeconomic status and diagnosis, treatment, and mortality in men with prostate cancer. Nationwide population-based study. Int J Cancer. 2018;142:2478–2484.
   PubMed Web of Science ®Google Scholar
• Karlsen RV, Larsen SB, Christensen J, et al. PSA testing without clinical indication for prostate cancer in relation to socio-demographic and clinical characteristics in the Danish Diet, Cancer and Health Study. Acta Oncol. 2013;52:1609–1614.
   PubMed Web of Science ®Google Scholar